Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)Suresh S. Ramalingam, Claude El Kouri, Stephen Della‐Fiorentina et al.|Annals of Oncology|2013Cited by 57
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastomaLucy Gately, Carmen Balañá, Carlos Mesía et al.|Journal of Neuro-Oncology|2023Cited by 5
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastomaLucy Gately, Carmen Balañá, Carlos Mesía et al.|Journal of Neuro-Oncology|2024Cited by 3
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)Lucy Gately, Carmen Balañá, Carlos Mesía et al.|Journal of Neuro-Oncology|2024Cited by 2
CTNI-54. A COMBINED ANALYSIS OF TWO RANDOMISED STUDIES EXPLORING THE IMPACT OF EXTENDED POST-RADIATION TEMOZOLOMIDE ON SURVIVAL OUTCOMES IN NEWLY DIAGNOSED GLIOBLASTOMALucy Gately, Carmen Balañá, Carlos Mesía et al.|Neuro-Oncology|2023Cited by 0